Literature DB >> 8487273

Suicide risk in Huntington's disease.

L Di Maio1, F Squitieri, G Napolitano, G Campanella, J A Trofatter, P M Conneally.   

Abstract

In order to evaluate the relevance of suicide risk in families affected by Huntington's disease (HD), 2793 subjects registered with the National Huntington's Disease Research Roster were studied. Suicide was the reported cause of death in 205 subjects (7.3%). This group included affected and possibly affected subjects, subjects at 50% and 25% risk, possibly at risk subjects, and normal relatives. In all categories suicide was more frequent than in the general US population. The data suggest that suicide is quite frequent in some families with HD. This increased suicide risk must be carefully considered in planning genetic counselling for predictive testing in HD.

Entities:  

Mesh:

Year:  1993        PMID: 8487273      PMCID: PMC1016335          DOI: 10.1136/jmg.30.4.293

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  8 in total

1.  Huntington's chorea in Michigan. I. Demography and genetics.

Authors:  T E REED; J H CHANDLER
Journal:  Am J Hum Genet       Date:  1958-06       Impact factor: 11.025

2.  Huntington's chorea in the West of Scotland.

Authors:  J M Bolt
Journal:  Br J Psychiatry       Date:  1970-03       Impact factor: 9.319

3.  Socio-psychiatric consequences of Huntington's disease.

Authors:  K Dewhurst; J E Oliver; A L McKnight
Journal:  Br J Psychiatry       Date:  1970-03       Impact factor: 9.319

4.  Comment.

Authors:  R Harris
Journal:  J Med Genet       Date:  1978-02       Impact factor: 6.318

5.  Genetic family history questionnaire.

Authors:  J Cole; P M Conneally; M E Hodes; A D Merritt
Journal:  J Med Genet       Date:  1978-02       Impact factor: 6.318

6.  Increased rate of suicide among patients with Huntington's disease.

Authors:  M Schoenfeld; R H Myers; L A Cupples; B Berkman; D S Sax; E Clark
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-12       Impact factor: 10.154

7.  Family history of suicide.

Authors:  A Roy
Journal:  Arch Gen Psychiatry       Date:  1983-09

8.  Suicide and attempted suicide in Huntington disease: implications for preclinical testing of persons at risk.

Authors:  L A Farrer
Journal:  Am J Med Genet       Date:  1986-06
  8 in total
  33 in total

Review 1.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

2.  Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators.

Authors:  Samuel Frank
Journal:  BMC Neurol       Date:  2009-12-18       Impact factor: 2.474

Review 3.  Huntington's disease: the coming of age.

Authors:  Mritunjay Pandey; Usha Rajamma
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 4.  Cause or compensation?-Altered neuronal Ca2+ handling in Huntington's disease.

Authors:  James P Mackay; Wissam B Nassrallah; Lynn A Raymond
Journal:  CNS Neurosci Ther       Date:  2018-02-09       Impact factor: 5.243

Review 5.  Basal ganglia volumetric studies in affective disorder: what did we learn in the last 15 years?

Authors:  R M Bonelli; H-P Kapfhammer; S S Pillay; D A Yurgelun-Todd
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

Review 6.  Progress in developing transgenic monkey model for Huntington's disease.

Authors:  Brooke R Snyder; Anthony W S Chan
Journal:  J Neural Transm (Vienna)       Date:  2017-11-10       Impact factor: 3.575

7.  A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease.

Authors:  E W Almqvist; M Bloch; R Brinkman; D Craufurd; M R Hayden
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

Review 8.  An overview of psychiatric symptoms in Huntington's disease.

Authors:  K E Anderson; K S Marder
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

9.  Suicidal behavior in prodromal Huntington disease.

Authors:  Jess G Fiedorowicz; James A Mills; Adam Ruggle; Douglas Langbehn; Jane S Paulsen
Journal:  Neurodegener Dis       Date:  2011-06-09       Impact factor: 2.977

Review 10.  Treatment of Huntington's disease.

Authors:  Samuel Frank
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.